Member Info for TrickyEFC

Gonna get close to the 0.5s

To much going on for this to be valued at just £20mill.

Long term holders increasing holdings and now Oberon are out the mms ain't getting a steady flow of shares.

The supply v demand issue is about to kick off again as we approach an important time in relation to important news.

50% for the week £30mill value. Still cheap.

0

If stage 3 comes back with similar results this is gonna be sooooo big.

Away from the science the Ethics and Morality of this maybe a bigger selling point. Patent cliff happening pharma's looking for new revenue streams and this one comes with no health risks or bad side effects and is for a massive unmet market.

Let's roll on up some more this week.

Wide ranging benefits and that's for non drinkers too.

£32 billion cost to America each year. Just one of many avenues svns can help with.

Every day, about 34 people in the United States die in drunk-driving crashes — that's one person every 42 minutes. In 2023, 12,429 people died in alcohol-impaired driving traffic deaths. These deaths were all preventable.

In days

Pre trail Sober 7 days outta 365

Post 301 days sober.

When ya look at it that way 💪💪

Insane stuff

Covering bases. Recent CNS AI and funding goes lovely with this appointment.

Seriously the quality and synergy of these appointments to Solvonis is fantastic stuff to see.

Solvonis Therapeutics plc (LSE:SVNS), an innovative biotechnology company co-developing therapeutics for mental health disorders, is pleased to announce the appointment of pharmaceutical industry veteran, Dr. Renata Crome DSc, MBA, MFPM, as an independent Non-Executive Director, effective from 11 March 2025.

Dr. Crome brings over 40 years of experience in scientific and clinical development, regulatory approval, and commercialisation of breakthrough medicines. A recognised leader in CNS (Central Nervous System), oncology, and infectious diseases, Dr. Crome has guided more than 100 novel therapies from early-stage research to first-in-human clinical trials.

During her 30-year tenure at Roche, Dr. Crome progressed through increasingly senior roles, ultimately becoming Deputy Head of Early Development & Global Head of Development Operations. In this capacity, she led a team of over 250 professionals and managed a portfolio of more than 100 early development programmes across several therapeutic areas, including CNS, a key area of focus for Solvonis.

Dr. Crome's strategic leadership has been pivotal in the commercialisation of several blockbuster drugs, including leading the prioritisation of Avastin® and Tamiflu®, resulting in rapid regulatory approvals and the realisation of US$7 billion and US$3 billion peak annual sales respectively for Roche. These achievements reflect her ability to drive the development of impactful treatments, especially in therapeutic areas closely aligned with Solvonis's commitment to addressing mental health and addiction.

Currently, Dr. Crome consults for Novo Nordisk, advising on early-stage drug development strategies, and previously led the UK Government's UKRI-sponsored COVID-19 treatments programme.

Dr. Crome also served as a Non-Executive Director at Camcon Robotics and is a Trustee for the PTEN Research Foundation, Success Charity and Isabel Hospice. Her involvement in academia includes lecturing at the University of Hertfordshire and chairing the Infectious Diseases Expert Group within the Faculty of Pharmaceutical Medicine's Policy & Communications Group.

With the lady in Exeter Dr King (hope got the name right)

Along with Nutt, Dennis and Anthony is clear to see they are an experienced team and have thought about how to navigate this pathway with least resistance covering so many bases.

Some good questions asked by that archer bloke.

Regarding the ability to have therapists in place.

Was delighted with how Anthony responded with the 120page method manual and how they will overcome what could of been a tricky hurdle.

Nobody minds a copy n paste of these rather bullish use of words by Anthony

Svn 002 if your listeners like the sales curve on Spravato ($1.3b and climbing) then theyll like what we have planned for SVN002, many U.S. multinationals not just J & J, lots of deals over $5B for mental health pharma.

Wookie lead candidate by end of July however could be august though as some of the Italian boffins are going on holiday 😂

Cheers lama. By far the best interview Anthony has done so far.

This went deeper than anything before. He was excellent on explaining the science behind treatment for svns 01 and how the whole process will be rolled out.

Was so much juicy stuff to take in.

However One bit that sticks out to me was when he mentioned about the situation in the USA regarding mental health drugs/treatments being very fondly supported and he says 'ACCESS TO NON DILUTIVE FUNDING'

Hope the suckers take it down to 0.25 next week.

Please do.

Long run this is lovely. Jubbly

Nice move Andy.

Love Dumfries and Galloway area..

Lovely move for ya

£12k richer dolphins in ya front view.

Andy ya vest be on holiday 🤪🤪🤪😂

As I actually promoted this on other BBs sub 0.14p I feel vindicated to tell people to check out MKA.

Svns story so far is golden and the MKA recycling of rem looks too good to not have a stab.

Solvonis we mayntirnmoutn o be the Nutts but we have the Nutt regardless.

Today but brought my ave up on trading account some what but getting to but less than 10% premium to those 3 insiders seems an astute purchase to me and that's after 5 points .

No chance of tears next week we touching the Formby 40s

Say no more. Good weekend all come to England ha anlaugh get a tan. Yippee Kai iiii

Ps remember it all ain't this easy.

Ie syn got butt fooked this week on that one. Took me medication and put what was left in here. Less stress and be crazy not to.

Reeves will get to tickle my anus

think about 18/19 mill

had about 15mill and bought about £6k yesteday or day before and about 3ill today at the bell.

i think i have fooked up athis week on regards to tax.

got £4k allowance left and have bought the 16 grand this week in trading account. so will prov look to sell 4/5 million next week. put another 4k in isa. i am a bit loose now with position onnthisnshare but know it's very healthy.

the trading aspect is great as it keeps ya from being bored and means ya can just forget about ya isa.

i am trading the other 16k. plan to sell at 0 .39p and then wait till next year for another 30kntax free. it i s going where it's going buying at plus 1.6p next year will be no worries.

i hope this makes sense as i am rather munted. enjoy the sunshine treat yaself as svns isnmaking us all money.

ps andynthis time two months a 10% raise will be worth over £15k to ya. believe in this ****

That's £10k is my last

🐴🐴🐴🐴

Stopped for some water

Plus all those recent sells at the days high